Pursuant to SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated 2nd July 2025, SMS Pharmaceuticals has submitted the report as of October 2025, in respect of the Special Window for re-lodgement of transfer requests for physical shares. The enclosed report, obtained from its Registrar and Share Transfer Agent of the Company, Aarthi Consultants, Hyderabad confirms the status of transfer requests received, processed, approved, and rejected, during the said period.
The above information is a part of company’s filings submitted to BSE.
